{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T14:22:39Z","timestamp":1775744559708,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T00:00:00Z","timestamp":1606867200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004480","name":"Natural Science Foundation of Shanxi Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004480","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013101","name":"Scientific Research Plan Projects of Shaanxi Education Department","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013101","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007515","name":"National Youth Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007515","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.cyto.2020.155391","type":"journal-article","created":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T19:48:24Z","timestamp":1607370504000},"page":"155391","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Involvement of the cytokine TWEAK in the pathogenesis of psoriasis vulgaris, pustular psoriasis, and erythrodermic psoriasis"],"prefix":"10.1016","volume":"138","author":[{"given":"Huixia","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sijia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengfei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3493-7198","authenticated-orcid":false,"given":"Yumin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3936-1834","authenticated-orcid":false,"given":"Yale","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2020.155391_b0005","doi-asserted-by":"crossref","unstructured":"X. Ding, T. Wang, Y. Shen, X. Wang, C. Zhou, S. Tian, Y. Liu, G. Peng, J. Zhou, S. Xue, R. Wang, Y. Tang, X. Meng, G. Pei, Y. Bai, Q. Liu, H. Li, J. Zhang, Prevalence of psoriasis in China: A population-based study in six cities, Eur. J. Dermatol. 22 (2012) 663\u2013667. https:\/\/doi.org\/10.1684\/ejd.2012.1802.","DOI":"10.1684\/ejd.2012.1802"},{"key":"10.1016\/j.cyto.2020.155391_b0010","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/HNP.0000000000000180","article-title":"Integrative approach to Psoriasis Vulgaris","volume":"32","author":"Ljubenovic","year":"2018","journal-title":"Holist. Nurs. Pract."},{"issue":"12","key":"10.1016\/j.cyto.2020.155391_b0015","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1016\/j.jid.2016.07.008","article-title":"IL-17 responses are the dominant inflammatory signal linking inverse, erythrodermic, and chronic plaque psoriasis","volume":"136","author":"Xing","year":"2016","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.cyto.2020.155391_b0020","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jaci.2016.08.056","article-title":"IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis","volume":"140","author":"Johnston","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2020.155391_b0025","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.cyto.2014.12.014","article-title":"Cytokines in psoriasis","volume":"73","author":"Baliwag","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2020.155391_b0030","doi-asserted-by":"crossref","first-page":"6746870","DOI":"10.1155\/2017\/6746870","article-title":"TWEAK\/Fn14 activation participates in skin inflammation","volume":"2017","author":"Liu","year":"2017","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.cyto.2020.155391_b0035","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3389\/fimmu.2017.00651","article-title":"TWEAK\/Fn14 activation participates in Ro52-mediated photosensitization in cutaneous lupus erythematosus","volume":"8","author":"Liu","year":"2017","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.cyto.2020.155391_b0040","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.jid.2017.03.019","article-title":"TWEAK\/Fn14 activation contributes to the pathogenesis of bullous pemphigoid","volume":"137","author":"Liu","year":"2017","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.cyto.2020.155391_b0045","doi-asserted-by":"crossref","first-page":"R26","DOI":"10.1186\/ar4454","article-title":"Expression of tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 in patients with polymyositis and dermatomyositis","volume":"16","author":"Peng","year":"2014","journal-title":"Arthritis Res. Ther."},{"issue":"4","key":"10.1016\/j.cyto.2020.155391_b0050","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrrheum.2017.22","article-title":"Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases","volume":"13","author":"Croft","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"issue":"2","key":"10.1016\/j.cyto.2020.155391_b0055","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/ijd.14646","article-title":"Changes in serum TNF\u2010like weak inducer of apoptosis (TWEAK) levels and Psoriasis Area Severity Index (PASI) scores in plaque psoriasis patients treated with conventional versus anti\u2010TNF treatments","volume":"59","author":"Engin","year":"2020","journal-title":"Int. J. Dermatol."},{"issue":"1","key":"10.1016\/j.cyto.2020.155391_b0060","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/exd.12820","article-title":"TWEAK\/Fn14 activation induces keratinocyte proliferation under psoriatic inflammation","volume":"25","author":"Cheng","year":"2016","journal-title":"Exp. Dermatol."},{"issue":"4","key":"10.1016\/j.cyto.2020.155391_b0065","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jaad.2004.04.012","article-title":"Evaluating psoriasis with psoriasis area and severity index, psoriasis global assessment, and lattice system physician's global assessment","volume":"51","author":"Langley","year":"2004","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.cyto.2020.155391_b0070","doi-asserted-by":"crossref","unstructured":"T. Henseler, K. Schmitt\u2010Rau, A comparison between BSA, PASI, PLASI and SAPASI as measures of disease severity and improvement by therapy in patients with psoriasis, Int. J. Dermatol. 47 (2008) 1019\u20131023. https:\/\/doi.org\/10.1111\/j.1365-4632.2008.03753.x.","DOI":"10.1111\/j.1365-4632.2008.03753.x"},{"issue":"9","key":"10.1016\/j.cyto.2020.155391_b0075","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/1346-8138.13306","article-title":"Efficacy and safety of secukinumab in patients with generalized pustular psoriasis: a 52-week analysis from phase III open-label multicenter Japanese study","volume":"43","author":"Imafuku","year":"2016","journal-title":"J. Dermatol."},{"issue":"5","key":"10.1016\/j.cyto.2020.155391_b0080","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/1346-8138.14294","article-title":"Guselkumab, a human interleukin-23 monoclonal antibody in Japanese patients with generalized pustular psoriasis and erythrodermic psoriasis: efficacy and safety analyses of a 52-week, phase 3, multicenter, open-label study","volume":"45","author":"Sano","year":"2018","journal-title":"J. Dermatol."},{"issue":"8","key":"10.1016\/j.cyto.2020.155391_b0085","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-018-0820-6","article-title":"Fn14 deficiency ameliorates psoriasis-like skin disease in a murine model","volume":"9","author":"Peng","year":"2018","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.cyto.2020.155391_b0090","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1213\/ANE.0000000000002864","article-title":"Correlation coefficients: appropriate use and interpretation","volume":"126","author":"Schober","year":"2018","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.cyto.2020.155391_b0095","doi-asserted-by":"crossref","unstructured":"T. Chen, Z.-P. Guo, M.-M. Li, J.-Y. Li, X.-Y. Jiao, Y.-H. Zhang, H.-J. Liu, Tumour necrosis factor-like weak inducer of apoptosis (TWEAK), an important mediator of endothelial inflammation, is associated with the pathogenesis of Henoch-Schonlein purpura, Clin. Exp. Immunol. 166 (2011) 64\u201371. https:\/\/doi.org\/10.1111\/j.1365-2249.2011.04442.x.","DOI":"10.1111\/j.1365-2249.2011.04442.x"},{"issue":"3","key":"10.1016\/j.cyto.2020.155391_b0100","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cyto.2010.12.003","article-title":"Increased serum TWEAK levels in Psoriatic arthritis: relationship with disease activity and matrix metalloproteinase-3 serum levels","volume":"53","author":"Xia","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2020.155391_b0105","first-page":"780","article-title":"Expression of TWEAK in normal human skin, dermatitis and epidermal neoplasms: association with proliferation and differentiation of keratinocytes","volume":"38","author":"Peternel","year":"2011","journal-title":"J. Cutan. Pathol."},{"issue":"1","key":"10.1016\/j.cyto.2020.155391_b0110","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15395","article-title":"TWEAK mediates inflammation in experimental atopic dermatitis and psoriasis","volume":"8","author":"Sidler","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cyto.2020.155391_b0115","doi-asserted-by":"crossref","first-page":"84","DOI":"10.5114\/pdia.2014.40920","article-title":"Chemokines and cytokines network in the pathogenesis of the inflammatory skin diseases: atopic dermatitis, psoriasis and skin mastocytosis","volume":"2","author":"Nedoszytko","year":"2014","journal-title":"Postepy. Dermatol. Alergol."},{"key":"10.1016\/j.cyto.2020.155391_b0120","doi-asserted-by":"crossref","unstructured":"Y.B. Choe, Y.J. Hwang, H.J. Hahn, J.W. Jung, H.J. Jung, Y.W. Lee, K.J. Ahn, J.I. Youn, A comparison of serum inflammatory cytokines according to phenotype in patients with psoriasis, Br. J. Dermatol. 167 (2012) 762\u2013767. https:\/\/doi.org\/10.1111\/j.1365-2133.2012.11038.x.","DOI":"10.1111\/j.1365-2133.2012.11038.x"},{"issue":"1","key":"10.1016\/j.cyto.2020.155391_b0125","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/bjd.14034","article-title":"Increased expression of interleukin\u201017 pathway genes in nonlesional skin of moderate\u2010to\u2010severe psoriasis vulgaris","volume":"174","author":"Chiricozzi","year":"2016","journal-title":"Br. J. Dermatol."},{"issue":"4","key":"10.1016\/j.cyto.2020.155391_b0130","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/jid.2012.426","article-title":"CD8 T cells and IFN-\u03b3 emerge as critical players for psoriasis in a novel model of mouse psoriasiform skin inflammation","volume":"133","author":"Di Meglio","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cyto.2020.155391_b0135","doi-asserted-by":"crossref","unstructured":"P.C.M. Res, G. Piskin, O.J. de Boer, C.M. van der Loos, P. Teeling, J.D. Bos, M.B.M. Teunissen, Overrepresentation of IL-17A and IL-22 producing CD8 T cells in lesional skin suggests their involvement in the pathogenesis of psoriasis, PloS One. 5 (2010) e14108. https:\/\/doi.org\/10.1371\/journal.pone.0014108.","DOI":"10.1371\/journal.pone.0014108"},{"issue":"3","key":"10.1016\/j.cyto.2020.155391_b0140","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jcmgh.2019.05.009","article-title":"TWEAK\/Fn14 Is overexpressed in Crohn\u2019s disease and mediates experimental ileitis by regulating critical innate and adaptive immune pathways","volume":"8","author":"Di Martino","year":"2019","journal-title":"Cellular Mol. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.cyto.2020.155391_b0145","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.cell.2005.09.022","article-title":"TWEAK attenuates the transition from innate to adaptive immunity","volume":"123","author":"Maecker","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.cyto.2020.155391_b0150","first-page":"93","article-title":"Erythrodermic psoriasis: pathophysiology and current treatment perspectives","volume":"6","author":"Singh","year":"2016","journal-title":"Psoriasis Auckl. NZ."},{"issue":"1","key":"10.1016\/j.cyto.2020.155391_b0155","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/jid.2008.194","article-title":"Psoriasis is characterized by accumulation of immunostimulatory and Th1\/Th17 cell-polarizing myeloid dendritic cells","volume":"129","author":"Zaba","year":"2009","journal-title":"J. Invest. Dermatol."},{"issue":"4","key":"10.1016\/j.cyto.2020.155391_b0160","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/jid.2014.532","article-title":"IL-36\u03b3 (IL-1F9) is a biomarker for psoriasis skin lesions","volume":"135","author":"D'Erme","year":"2015","journal-title":"J. Invest. Dermatol."},{"issue":"3","key":"10.1016\/j.cyto.2020.155391_b0165","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2340\/00015555-2265","article-title":"Interleukin-36\u03b3 (IL-1F9) identifies psoriasis among patients with erythroderma","volume":"96","author":"Braegelmann","year":"2016","journal-title":"Acta Derm. Venerol."},{"issue":"10","key":"10.1016\/j.cyto.2020.155391_b0170","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.7150\/ijms.20809","article-title":"IL-36\u03b3 inhibits differentiation and induces inflammation of keratinocyte via Wnt signaling pathway in psoriasis","volume":"14","author":"Wang","year":"2017","journal-title":"Int. J. Med. Sci."},{"issue":"12","key":"10.1016\/j.cyto.2020.155391_b0175","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.4049\/jimmunol.1301481","article-title":"IL-36 promotes myeloid cell infiltration, activation, and inflammatory activity in skin","volume":"192","author":"Foster","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2020.155391_b0180","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02532","article-title":"Biology of IL-36 signaling and its role in systemic inflammatory diseases","volume":"10","author":"Yuan","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2020.155391_b0185","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-45626-w","article-title":"Small molecule IL-36\u03b3 antagonist as a novel therapeutic approach for plaque psoriasis","volume":"9","author":"Todorovi\u0107","year":"2019","journal-title":"Sci. Rep."},{"issue":"51","key":"10.1016\/j.cyto.2020.155391_b0190","doi-asserted-by":"crossref","first-page":"21795","DOI":"10.1073\/pnas.0911472106","article-title":"Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production","volume":"106","author":"Fujita","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"9","key":"10.1016\/j.cyto.2020.155391_b0195","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.it.2010.06.004","article-title":"IL-17 and IL-22: siblings, not twins","volume":"31","author":"Eyerich","year":"2010","journal-title":"Trends Immunol."},{"issue":"7","key":"10.1016\/j.cyto.2020.155391_b0200","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/jamadermatol.2015.2","article-title":"Immunologic overlap of helper T-cell subtypes 17 and 22 in erythrodermic psoriasis and atopic dermatitis","volume":"151","author":"Moy","year":"2015","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.cyto.2020.155391_b0205","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/cei.12761","article-title":"Distinct expression of interleukin (IL)-36\u03b1, \u03b2 and \u03b3, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn\u2019s disease","volume":"184","author":"Boutet","year":"2016","journal-title":"Clin. Exp. Immunol."},{"issue":"4","key":"10.1016\/j.cyto.2020.155391_b0210","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1189\/jlb.3RI1014-495R","article-title":"Regulation and function of interleukin-36 cytokines in homeostasis and pathological conditions","volume":"97","author":"Gabay","year":"2015","journal-title":"J. Leukoc. Biol."},{"issue":"7","key":"10.1016\/j.cyto.2020.155391_b0215","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJMoa1013068","article-title":"Interleukin-36\u2013receptor antagonist deficiency and generalized pustular psoriasis","volume":"365","author":"Marrakchi","year":"2011","journal-title":"N Engl. J. Med."},{"issue":"10","key":"10.1016\/j.cyto.2020.155391_b0220","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1111\/jdv.14949","article-title":"Generalized pustular psoriasis: a review and update on treatment","volume":"32","author":"Hoegler","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"4","key":"10.1016\/j.cyto.2020.155391_b0225","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.coph.2012.02.009","article-title":"IL-36 in psoriasis","volume":"12","author":"Towne","year":"2012","journal-title":"Curr. Opin. Pharmacol."},{"issue":"9","key":"10.1016\/j.cyto.2020.155391_b0230","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.3390\/ijms20071649","article-title":"IL-36 cytokines: regulators of inflammatory responses and their emerging role in immunology of reproduction","volume":"20","author":"Murrieta-Coxca","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1 Supplement","key":"10.1016\/j.cyto.2020.155391_b0235","doi-asserted-by":"crossref","first-page":"237.1","DOI":"10.4049\/jimmunol.204.Supp.237.1","article-title":"Tumor necrosis factor like weak inducer of apoptosis (TWEAK) promotes inflammatory activity in keratinocytes with IL-17 and TNF to drive psoriasis","volume":"204","author":"Gupta","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2020.155391_b0240","doi-asserted-by":"crossref","first-page":"410","DOI":"10.5455\/medarh.2018.72.410-413","article-title":"Serum concentrations of interferon gamma (IFN-\u03b3) in patients with psoriasis: correlation with clinical type and severity of the disease","volume":"72","author":"Kurtovic","year":"2018","journal-title":"Med. Arch."},{"key":"10.1016\/j.cyto.2020.155391_b0245","doi-asserted-by":"crossref","unstructured":"S. Vigne, G. Palmer, C. Lamacchia, P. Martin, D. Talabot-Ayer, E. Rodriguez, F. Ronchi, F. Sallusto, H. Dinh, J.E. Sims, C. Gabay, IL-36R ligands are potent regulators of dendritic and T cells, Blood. 118 (2011) 5813\u20135823. https:\/\/doi.org\/10.1182\/blood-2011-05-356873.","DOI":"10.1182\/blood-2011-05-356873"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466620304075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466620304075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:58:08Z","timestamp":1760907488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466620304075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":49,"alternative-id":["S1043466620304075"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2020.155391","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Involvement of the cytokine TWEAK in the pathogenesis of psoriasis vulgaris, pustular psoriasis, and erythrodermic psoriasis","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2020.155391","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"155391"}}